We are excited to announce that the Gagliardi Group, as part of the collaborative team with scientists from qBraid and MIT, has been selected as a performer in Phase 2 of the Wellcome Leap Quantum for Bio program. Our team is working to optimize fragmentation-based hybrid quantum-classical algorithms for healthcare applications, with the ultimate goal of running these algorithms on quantum hardware.
A special congratulations to Ruhee D’Cunha, who is working alongside Kanav Setia of qBraid Co.
Learn more here.